The field of rare cancer research is rapidly transforming, marked by significant progress in clinical trials and treatment strategies. Rare cancers, as defined by the National Cancer Institute, occur ...

In order to plan and conduct pediatric clinical trials we need to address the unique ethical issues. Children require a higher standard of ethics, regulatory and developmental consideration. Since ...

Congressional Republicans support enforcing diversity action plan requirements while distancing them from DEI rhetoric, amid uncertainty created by removal and altered reinstatement of FDA draft ...

From a trial design perspective, we’ve tried to make these trials as familiar to stakeholders – regulators, prescribers, payors – as possible. What’s remarkable here are the qualities of the drug that ...

Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: Educational ...

As agentic AI, automated data harmonization, and real-time monitoring reshape clinical development, the organizations seeing ...

How can you design and execute early phase trials to get the results needed with limited resources and time? We need to balance what we can do and the resources we have with what needs to be done for ...

Cancer is not static. It evolves, mutates, adapts, and resists. That volatility makes clinical trials a critical component of cancer treatment. Yet despite advances resulting from these studies, only ...

Stress has often been called the psychological problem of the 21 st century. Though stress can have some advantageous effects when it comes to productivity, it can also be significantly detrimental to ...

Different groups of people—men, women, children, and people of different races or ethnic backgrounds—respond differently to different drugs. Clinical trials are supposed to drive advances in medicine ...

Dr. Hope Rugo and Dr. Vivek Subbiah discuss innovative trial designs to enable robust studies for smaller patient populations, as well as the promise of precision medicine, novel therapeutic ...